Planning Post‐Launch Evidence Generation: Lessons From France, England and Spain
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Seamus Kent, Francois Meyer, Alina Pavel, Carlos Martin Saborido, Catrin Austin, Steve Williamson, Joshua Ray, Karen Facey |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Integrated Evidence Planning for Enhancing Patient Care: Harnessing the Power of Real‐World Evidence
by: Gorana Capkun, et al.
Published: (2025)
by: Gorana Capkun, et al.
Published: (2025)
Balancing Reassurance and Vigilance: Real‐World Evidence in Post‐Marketing Drug Safety
by: Yow‐Ming C. Wang, et al.
Published: (2026)
by: Yow‐Ming C. Wang, et al.
Published: (2026)
Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World
by: Jens Grueger, et al.
Published: (2025)
by: Jens Grueger, et al.
Published: (2025)
Temporal Trends in Medical and Surgical Management of Ulcerative Colitis in England: 2003–2020
by: J. Couch, et al.
Published: (2025)
by: J. Couch, et al.
Published: (2025)
Editorial: Three‐Dimensional (3D) Geometric Modelling in TIPS Implantation—A Further Step Toward Personalised Portal Pressure Reduction and Pre‐Procedural Planning. Authors' Reply
by: Markus Kimmann, et al.
Published: (2025)
by: Markus Kimmann, et al.
Published: (2025)
Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain‐DDR Study
by: Ana Alberola, et al.
Published: (2026)
by: Ana Alberola, et al.
Published: (2026)
Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study
by: Henk‐Jan Guchelaar, et al.
Published: (2025)
by: Henk‐Jan Guchelaar, et al.
Published: (2025)
Maternal‐to‐Infant Transfer of Medications for Type 2 Diabetes Mellitus Via Breastmilk: A Systematic Review of Available Evidence and Clinical Guidelines
by: Katherine Richardson, et al.
Published: (2026)
by: Katherine Richardson, et al.
Published: (2026)
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study
by: Ronen Stein, et al.
Published: (2025)
by: Ronen Stein, et al.
Published: (2025)
Editorial: Toward Safer Pain Management in IBD—Lessons From Prescription Patterns
by: Shabari Shenoy, et al.
Published: (2025)
by: Shabari Shenoy, et al.
Published: (2025)
Editorial: Toward Safer Pain Management in IBD—Lessons From Prescription Patterns. Authors' Reply
by: Samantha Baillie, et al.
Published: (2025)
by: Samantha Baillie, et al.
Published: (2025)
Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation
by: Vlasios Gourgiotis, et al.
Published: (2025)
by: Vlasios Gourgiotis, et al.
Published: (2025)
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned
by: Tyler Shugg, et al.
Published: (2024)
by: Tyler Shugg, et al.
Published: (2024)
Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration
by: Rebecca A. Miksad
Published: (2024)
by: Rebecca A. Miksad
Published: (2024)
Clinical Evidence 2030
by: Peter Arlett, et al.
Published: (2025)
by: Peter Arlett, et al.
Published: (2025)
Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials
by: Hermann Brenner, et al.
Published: (2025)
by: Hermann Brenner, et al.
Published: (2025)
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms–still a long way to go…
by: Sabine Roman, et al.
Published: (2024)
by: Sabine Roman, et al.
Published: (2024)
New Horizons for Clinical Pharmacology & Therapeutics : Global Outreach for Optimal Patient Outcomes
by: Karen Rowland Yeo
Published: (2025)
by: Karen Rowland Yeo
Published: (2025)
Tailoring Drug Therapy: Bridging Data Science and Clinical Reality
by: Karen Rowland Yeo
Published: (2026)
by: Karen Rowland Yeo
Published: (2026)
Registered Clinical Trials of Ayahuasca and DMT : A Scoping Review
by: Tijana Stojanović, et al.
Published: (2026)
by: Tijana Stojanović, et al.
Published: (2026)
Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
by: Joshua Reid, et al.
Published: (2024)
by: Joshua Reid, et al.
Published: (2024)
Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet? Author's Reply
by: Aurelien Amiot, et al.
Published: (2025)
by: Aurelien Amiot, et al.
Published: (2025)
Editorial: Another brick in the CDST wall
by: Aurelien Amiot, et al.
Published: (2024)
by: Aurelien Amiot, et al.
Published: (2024)
Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability
by: Sarah K. Emond, et al.
Published: (2025)
by: Sarah K. Emond, et al.
Published: (2025)
Letter: Identifying the Best Model for Predicting Post‐SVR HCC
by: Hidenori Toyoda
Published: (2025)
by: Hidenori Toyoda
Published: (2025)
The Serotonin 2B (5‐ HT2B ) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression
by: Gia Han Le, et al.
Published: (2026)
by: Gia Han Le, et al.
Published: (2026)
Antiplatelet Resumption Timing in Post‐Percutaneous Coronary Intervention Gastrointestinal Bleeding
by: Darrick K. Li, et al.
Published: (2026)
by: Darrick K. Li, et al.
Published: (2026)
Prevalence and prognosis of patients with MASLD ‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study
by: Philippe Sultanik, et al.
Published: (2024)
by: Philippe Sultanik, et al.
Published: (2024)
Post‐Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing
by: Ian T.T. Liu, et al.
Published: (2026)
by: Ian T.T. Liu, et al.
Published: (2026)
The Use of Real‐World Evidence for Regulatory Decisions in China
by: Jiayue Xu, et al.
Published: (2024)
by: Jiayue Xu, et al.
Published: (2024)
FRAME: Framework for Real‐World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness – An Evaluation of Regulatory and Health Technology Assessment Decision Making
by: Gianmario Candore, et al.
Published: (2025)
by: Gianmario Candore, et al.
Published: (2025)
Letter: Post‐Banding Ulcer Bleeding Is More Common With Urgent EBL and Renal Dysfunction
by: Jurij Maurer, et al.
Published: (2026)
by: Jurij Maurer, et al.
Published: (2026)
Letter: Post‐endoscopic management after upper gastrointestinal bleeding—Replenishment of iron loss
by: Palle Bager, et al.
Published: (2024)
by: Palle Bager, et al.
Published: (2024)
Evidence Generation for Drugs and Biological Products isn't Magic or Myth
by: John Concato, et al.
Published: (2025)
by: John Concato, et al.
Published: (2025)
Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence
by: Wenqi Dong, et al.
Published: (2025)
by: Wenqi Dong, et al.
Published: (2025)
Impact of Regulatory Post‐Market Safety Advisories on Prescribing Practices: An Interrupted Time Series Analysis
by: Seonji Kim, et al.
Published: (2025)
by: Seonji Kim, et al.
Published: (2025)
Letter: Gastroparesis in Lung Transplantation: Time to Reframe and Standardise Post‐Transplant Foregut Motility Evaluation
by: Luisa Bertin, et al.
Published: (2026)
by: Luisa Bertin, et al.
Published: (2026)
Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT ‐ DUPLICATE Analysis
by: Phyo Than Htoo, et al.
Published: (2026)
by: Phyo Than Htoo, et al.
Published: (2026)
Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease
by: Javier Chahuán, et al.
Published: (2026)
by: Javier Chahuán, et al.
Published: (2026)
Review article: Evidence‐based dietary management of inflammatory bowel disease
by: Peter R. Gibson, et al.
Published: (2024)
by: Peter R. Gibson, et al.
Published: (2024)
Similar Items
-
Integrated Evidence Planning for Enhancing Patient Care: Harnessing the Power of Real‐World Evidence
by: Gorana Capkun, et al.
Published: (2025) -
Balancing Reassurance and Vigilance: Real‐World Evidence in Post‐Marketing Drug Safety
by: Yow‐Ming C. Wang, et al.
Published: (2026) -
Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World
by: Jens Grueger, et al.
Published: (2025) -
Temporal Trends in Medical and Surgical Management of Ulcerative Colitis in England: 2003–2020
by: J. Couch, et al.
Published: (2025) -
Editorial: Three‐Dimensional (3D) Geometric Modelling in TIPS Implantation—A Further Step Toward Personalised Portal Pressure Reduction and Pre‐Procedural Planning. Authors' Reply
by: Markus Kimmann, et al.
Published: (2025)